NLRP3 and atherosclerosis: In vivo studies have indicated its application for multiple NLRP3-driven diseases, such as type 2 diabetes, atherosclerosis, CNS disorders such as Alzheimer’s and Parkinson’s disease, inflammation and cancer135.